Rituximab and Pirfenidone in the Treatment of Steroid‐Refractory Bleomycin Lung Injury
<p dir="ltr">Bleomycin‐induced lung injury (BILI) is a well‐recognised but potentially life‐threatening complication of ABVD chemotherapy (adriamycin, bleomycin, vinblastine and dacarbazine), often requiring prompt diagnosis and intervention. We present a case of a 43‐year‐old female...
محفوظ في:
| المؤلف الرئيسي: | Aasir M. Suliman (14150217) (author) |
|---|---|
| مؤلفون آخرون: | Irfan Ul Haq (9853260) (author), Khalid Albsheer (21767534) (author), Mohamed Elgara (9538557) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
حسب: Lina Okar (14777164)
منشور في: (2023) -
Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
حسب: Mohamad Y. Khatib (11659459)
منشور في: (2020) -
Actinomyces‐infected bronchopulmonary sequestration: An uncommon pathogen in a rare anomaly
حسب: Aasir M. Suliman (14150217)
منشور في: (2024) -
Yeast Lacking the PP2A Phosphatase Regulatory Subunit Rts1 Sensitizes rad51 Mutants to Specific DNA Damaging Agents
حسب: Mustapha Aouida (417652)
منشور في: (2019) -
GSTP1 and NQO1 polymorphisms as risk indicators of lung cancer in Lebanon. (c2006)
حسب: Ahmarani, Lena Pierre
منشور في: (2006)